Anthrax lethal toxin (LT) was previously shown to enhance transcriptional activity of NF-B in tumor necrosis factor-␣-activated primary human endothelial cells. Here we show that this LT-mediated increase in NF-B activation is associated with the enhanced degradation of the inhibitory proteins IB␣ and IB but not IB⑀. Moreover, this was accompanied by enhanced activation of the IB kinase complex (IKK), which is responsible for targeting IB proteins for degradation. Importantly, LT enhancement of IB␣ degradation was completely blocked by a selective IKK inhibitor, whereas IB degradation was attenuated, suggesting a mechanistic link. Consistent with the above data, LT-cotreated cells show elevated phosphorylation of two IKK substrates, IB␣ and p65, both of which were blocked by incubation with the IKK inhibitor. Consistent with NF-B activation, LT increased transcription of the NF-B regulated gene CD40. Conversely, LT inhibited transcription of another NF-B-regulated gene, CCL2. This inhibition was linked to the LT-mediated suppression of another CCL2-regulating transcription factor, AP-1 (activator protein-1). These data suggest that LT-mediated enhancement of NF-B is IKKdependent, but importantly, the net effect of LT on the transcription of proinflammatory genes is driven by the cumulative effect of LT on the particular set of transcription factors that regulate a given promoter. Together, these findings provide new mechanistic insight on how LT may disrupt the host response to anthrax.